0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs of Abuse Testing Devices Market Research Report 2026
Published Date: 2026-03-31
|
Report Code: QYRE-Auto-30W6827
Home | Market Reports | Health| Substance Abuse| Drug & Alcohol Testing
Global Drugs of Abuse Testing Devices Market Insights and Forecast to 2028
BUY CHAPTERS

Global Drugs of Abuse Testing Devices Market Research Report 2026

Code: QYRE-Auto-30W6827
Report
2026-03-31
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drugs of Abuse Testing Devices Market

The global Drugs of Abuse Testing Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drugs of Abuse Testing Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Drugs of Abuse Testing Devices are used to test detect the presence of drugs such as marijuana, cocaine,
opiates, methamphetamine, amphetamines, PCP, benzodiazepine, barbiturates, methadone, tricyclic
antidepressants, ecstasy, and oxycodone etc in the urine, blood, saliva, hair, or sweat.
The report only studies Drugs of Abuse Testing reagent kits market.
Abbott is one of the biggest global key manufacturers of drugs of abuse testing devices, holds a share of about 30%, other key manufacturers include Thermo Fisher Scientific, Wondfo Biotech, and Roche, etc. India is the largest market, occupied for about 20 percent, followed by China. In terms of type, saliva testing type is the largest segment, with a share of about 30%, and in terms of application, the law enforcement segment holds a share of over 30 percent.
This report delivers a comprehensive overview of the global Drugs of Abuse Testing Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drugs of Abuse Testing Devices. The Drugs of Abuse Testing Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drugs of Abuse Testing Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drugs of Abuse Testing Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Drugs of Abuse Testing Devices Market Report

Report Metric Details
Report Name Drugs of Abuse Testing Devices Market
Segment by Type
  • Urine Testing
  • Saliva Testing
  • Blood Testing
  • Hair and Sweat Testing
  • Others
by Application
  • Hospital
  • Law Enforcement
  • Drug Treatment Center
  • Laboratory
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Thermo Fisher Scientific, Roche, Siemens Healthineers, Wondfo Biotech, Randox Laboratories, OraSure, Drager, Intec, Orient Gene Biotech, Hangzhou Biotest, Assure Tech (Hangzhou) Co, Aotai Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Drugs of Abuse Testing Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Drugs of Abuse Testing Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

What is the Abbott, Thermo Fisher Scientific, Wondfo Biotech, Roche share in Drugs of Abuse Testing Devices Market?

Ans: Abbott is one of the biggest global key manufacturers of drugs of abuse testing devices, holds a share of about 30%, other key manufacturers include Thermo Fisher Scientific, Wondfo Biotech, and Roche, etc.

What is the Drugs of Abuse Testing Devices Market share by type?

Ans: In terms of type, saliva testing type is the largest segment, with a share of about 30%, and in terms of application, the law enforcement segment holds a share of over 30 percent.

Who are the main players in the Drugs of Abuse Testing Devices Market report?

Ans: The main players in the Drugs of Abuse Testing Devices Market are Abbott, Thermo Fisher Scientific, Roche, Siemens Healthineers, Wondfo Biotech, Randox Laboratories, OraSure, Drager, Intec, Orient Gene Biotech, Hangzhou Biotest, Assure Tech (Hangzhou) Co, Aotai Bio

What are the Application segmentation covered in the Drugs of Abuse Testing Devices Market report?

Ans: The Applications covered in the Drugs of Abuse Testing Devices Market report are Hospital, Law Enforcement, Drug Treatment Center, Laboratory, Others

What are the Type segmentation covered in the Drugs of Abuse Testing Devices Market report?

Ans: The Types covered in the Drugs of Abuse Testing Devices Market report are Urine Testing, Saliva Testing, Blood Testing, Hair and Sweat Testing, Others

1 Drugs of Abuse Testing Devices Market Overview
1.1 Product Definition
1.2 Drugs of Abuse Testing Devices by Type
1.2.1 Global Drugs of Abuse Testing Devices Market Value by Type: 2025 vs 2032
1.2.2 Urine Testing
1.2.3 Saliva Testing
1.2.4 Blood Testing
1.2.5 Hair and Sweat Testing
1.2.6 Others
1.3 Drugs of Abuse Testing Devices by Application
1.3.1 Global Drugs of Abuse Testing Devices Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Law Enforcement
1.3.4 Drug Treatment Center
1.3.5 Laboratory
1.3.6 Others
1.4 Global Drugs of Abuse Testing Devices Market Size Estimates and Forecasts
1.4.1 Global Drugs of Abuse Testing Devices Revenue 2021–2032
1.4.2 Global Drugs of Abuse Testing Devices Sales 2021–2032
1.4.3 Global Drugs of Abuse Testing Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Drugs of Abuse Testing Devices Market Competition by Manufacturers
2.1 Global Drugs of Abuse Testing Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drugs of Abuse Testing Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drugs of Abuse Testing Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drugs of Abuse Testing Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drugs of Abuse Testing Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drugs of Abuse Testing Devices, Product Types and Applications
2.7 Global Key Manufacturers of Drugs of Abuse Testing Devices, Date of Entry into the Industry
2.8 Global Drugs of Abuse Testing Devices Market Competitive Situation and Trends
2.8.1 Global Drugs of Abuse Testing Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drugs of Abuse Testing Devices Players Market Share by Revenue
2.8.3 Global Drugs of Abuse Testing Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs of Abuse Testing Devices Market Scenario by Region
3.1 Global Drugs of Abuse Testing Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drugs of Abuse Testing Devices Sales by Region: 2021–2032
3.2.1 Global Drugs of Abuse Testing Devices Sales by Region: 2021–2026
3.2.2 Global Drugs of Abuse Testing Devices Sales by Region: 2027–2032
3.3 Global Drugs of Abuse Testing Devices Revenue by Region: 2021–2032
3.3.1 Global Drugs of Abuse Testing Devices Revenue by Region: 2021–2026
3.3.2 Global Drugs of Abuse Testing Devices Revenue by Region: 2027–2032
3.4 North America Drugs of Abuse Testing Devices Market Facts & Figures by Country
3.4.1 North America Drugs of Abuse Testing Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drugs of Abuse Testing Devices Sales by Country (2021–2032)
3.4.3 North America Drugs of Abuse Testing Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drugs of Abuse Testing Devices Market Facts & Figures by Country
3.5.1 Europe Drugs of Abuse Testing Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drugs of Abuse Testing Devices Sales by Country (2021–2032)
3.5.3 Europe Drugs of Abuse Testing Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs of Abuse Testing Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs of Abuse Testing Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drugs of Abuse Testing Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Drugs of Abuse Testing Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drugs of Abuse Testing Devices Market Facts & Figures by Country
3.7.1 Latin America Drugs of Abuse Testing Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drugs of Abuse Testing Devices Sales by Country (2021–2032)
3.7.3 Latin America Drugs of Abuse Testing Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs of Abuse Testing Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs of Abuse Testing Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drugs of Abuse Testing Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drugs of Abuse Testing Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs of Abuse Testing Devices Sales by Type (2021–2032)
4.1.1 Global Drugs of Abuse Testing Devices Sales by Type (2021–2026)
4.1.2 Global Drugs of Abuse Testing Devices Sales by Type (2027–2032)
4.1.3 Global Drugs of Abuse Testing Devices Sales Market Share by Type (2021–2032)
4.2 Global Drugs of Abuse Testing Devices Revenue by Type (2021–2032)
4.2.1 Global Drugs of Abuse Testing Devices Revenue by Type (2021–2026)
4.2.2 Global Drugs of Abuse Testing Devices Revenue by Type (2027–2032)
4.2.3 Global Drugs of Abuse Testing Devices Revenue Market Share by Type (2021–2032)
4.3 Global Drugs of Abuse Testing Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drugs of Abuse Testing Devices Sales by Application (2021–2032)
5.1.1 Global Drugs of Abuse Testing Devices Sales by Application (2021–2026)
5.1.2 Global Drugs of Abuse Testing Devices Sales by Application (2027–2032)
5.1.3 Global Drugs of Abuse Testing Devices Sales Market Share by Application (2021–2032)
5.2 Global Drugs of Abuse Testing Devices Revenue by Application (2021–2032)
5.2.1 Global Drugs of Abuse Testing Devices Revenue by Application (2021–2026)
5.2.2 Global Drugs of Abuse Testing Devices Revenue by Application (2027–2032)
5.2.3 Global Drugs of Abuse Testing Devices Revenue Market Share by Application (2021–2032)
5.3 Global Drugs of Abuse Testing Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Drugs of Abuse Testing Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Fisher Scientific Drugs of Abuse Testing Devices Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Roche Drugs of Abuse Testing Devices Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Siemens Healthineers
6.4.1 Siemens Healthineers Company Information
6.4.2 Siemens Healthineers Description and Business Overview
6.4.3 Siemens Healthineers Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Siemens Healthineers Drugs of Abuse Testing Devices Product Portfolio
6.4.5 Siemens Healthineers Recent Developments/Updates
6.5 Wondfo Biotech
6.5.1 Wondfo Biotech Company Information
6.5.2 Wondfo Biotech Description and Business Overview
6.5.3 Wondfo Biotech Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wondfo Biotech Drugs of Abuse Testing Devices Product Portfolio
6.5.5 Wondfo Biotech Recent Developments/Updates
6.6 Randox Laboratories
6.6.1 Randox Laboratories Company Information
6.6.2 Randox Laboratories Description and Business Overview
6.6.3 Randox Laboratories Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Randox Laboratories Drugs of Abuse Testing Devices Product Portfolio
6.6.5 Randox Laboratories Recent Developments/Updates
6.7 OraSure
6.7.1 OraSure Company Information
6.7.2 OraSure Description and Business Overview
6.7.3 OraSure Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 OraSure Drugs of Abuse Testing Devices Product Portfolio
6.7.5 OraSure Recent Developments/Updates
6.8 Drager
6.8.1 Drager Company Information
6.8.2 Drager Description and Business Overview
6.8.3 Drager Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Drager Drugs of Abuse Testing Devices Product Portfolio
6.8.5 Drager Recent Developments/Updates
6.9 Intec
6.9.1 Intec Company Information
6.9.2 Intec Description and Business Overview
6.9.3 Intec Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Intec Drugs of Abuse Testing Devices Product Portfolio
6.9.5 Intec Recent Developments/Updates
6.10 Orient Gene Biotech
6.10.1 Orient Gene Biotech Company Information
6.10.2 Orient Gene Biotech Description and Business Overview
6.10.3 Orient Gene Biotech Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Orient Gene Biotech Drugs of Abuse Testing Devices Product Portfolio
6.10.5 Orient Gene Biotech Recent Developments/Updates
6.11 Hangzhou Biotest
6.11.1 Hangzhou Biotest Company Information
6.11.2 Hangzhou Biotest Description and Business Overview
6.11.3 Hangzhou Biotest Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hangzhou Biotest Drugs of Abuse Testing Devices Product Portfolio
6.11.5 Hangzhou Biotest Recent Developments/Updates
6.12 Assure Tech (Hangzhou) Co
6.12.1 Assure Tech (Hangzhou) Co Company Information
6.12.2 Assure Tech (Hangzhou) Co Description and Business Overview
6.12.3 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Devices Product Portfolio
6.12.5 Assure Tech (Hangzhou) Co Recent Developments/Updates
6.13 Aotai Bio
6.13.1 Aotai Bio Company Information
6.13.2 Aotai Bio Description and Business Overview
6.13.3 Aotai Bio Drugs of Abuse Testing Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Aotai Bio Drugs of Abuse Testing Devices Product Portfolio
6.13.5 Aotai Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs of Abuse Testing Devices Industry Chain Analysis
7.2 Drugs of Abuse Testing Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs of Abuse Testing Devices Production Mode & Process Analysis
7.4 Drugs of Abuse Testing Devices Sales and Marketing
7.4.1 Drugs of Abuse Testing Devices Sales Channels
7.4.2 Drugs of Abuse Testing Devices Distributors
7.5 Drugs of Abuse Testing Devices Customer Analysis
8 Drugs of Abuse Testing Devices Market Dynamics
8.1 Drugs of Abuse Testing Devices Industry Trends
8.2 Drugs of Abuse Testing Devices Market Drivers
8.3 Drugs of Abuse Testing Devices Market Challenges
8.4 Drugs of Abuse Testing Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drugs of Abuse Testing Devices Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Drugs of Abuse Testing Devices Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Drugs of Abuse Testing Devices Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Drugs of Abuse Testing Devices Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Drugs of Abuse Testing Devices Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Drugs of Abuse Testing Devices Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Drugs of Abuse Testing Devices Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Drugs of Abuse Testing Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Drugs of Abuse Testing Devices, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Drugs of Abuse Testing Devices, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Drugs of Abuse Testing Devices, Product Types and Applications
 Table 12. Global Key Manufacturers of Drugs of Abuse Testing Devices, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drugs of Abuse Testing Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drugs of Abuse Testing Devices Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drugs of Abuse Testing Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Drugs of Abuse Testing Devices Sales by Region (K Units), 2021–2026
 Table 18. Global Drugs of Abuse Testing Devices Sales Market Share by Region (2021–2026)
 Table 19. Global Drugs of Abuse Testing Devices Sales by Region (K Units), 2027–2032
 Table 20. Global Drugs of Abuse Testing Devices Sales Market Share by Region (2027–2032)
 Table 21. Global Drugs of Abuse Testing Devices Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Drugs of Abuse Testing Devices Revenue Market Share by Region (2021–2026)
 Table 23. Global Drugs of Abuse Testing Devices Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Drugs of Abuse Testing Devices Revenue Market Share by Region (2027–2032)
 Table 25. North America Drugs of Abuse Testing Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Drugs of Abuse Testing Devices Sales by Country (K Units), 2021–2026
 Table 27. North America Drugs of Abuse Testing Devices Sales by Country (K Units), 2027–2032
 Table 28. North America Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Drugs of Abuse Testing Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Drugs of Abuse Testing Devices Sales by Country (K Units), 2021–2026
 Table 32. Europe Drugs of Abuse Testing Devices Sales by Country (K Units), 2027–2032
 Table 33. Europe Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Drugs of Abuse Testing Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Drugs of Abuse Testing Devices Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Drugs of Abuse Testing Devices Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Drugs of Abuse Testing Devices Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Drugs of Abuse Testing Devices Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Drugs of Abuse Testing Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Drugs of Abuse Testing Devices Sales by Country (K Units), 2021–2026
 Table 42. Latin America Drugs of Abuse Testing Devices Sales by Country (K Units), 2027–2032
 Table 43. Latin America Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Drugs of Abuse Testing Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Drugs of Abuse Testing Devices Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Drugs of Abuse Testing Devices Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Drugs of Abuse Testing Devices Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Drugs of Abuse Testing Devices Sales (K Units) by Type (2021–2026)
 Table 51. Global Drugs of Abuse Testing Devices Sales (K Units) by Type (2027–2032)
 Table 52. Global Drugs of Abuse Testing Devices Sales Market Share by Type (2021–2026)
 Table 53. Global Drugs of Abuse Testing Devices Sales Market Share by Type (2027–2032)
 Table 54. Global Drugs of Abuse Testing Devices Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Drugs of Abuse Testing Devices Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Drugs of Abuse Testing Devices Revenue Market Share by Type (2021–2026)
 Table 57. Global Drugs of Abuse Testing Devices Revenue Market Share by Type (2027–2032)
 Table 58. Global Drugs of Abuse Testing Devices Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Drugs of Abuse Testing Devices Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Drugs of Abuse Testing Devices Sales (K Units) by Application (2021–2026)
 Table 61. Global Drugs of Abuse Testing Devices Sales (K Units) by Application (2027–2032)
 Table 62. Global Drugs of Abuse Testing Devices Sales Market Share by Application (2021–2026)
 Table 63. Global Drugs of Abuse Testing Devices Sales Market Share by Application (2027–2032)
 Table 64. Global Drugs of Abuse Testing Devices Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Drugs of Abuse Testing Devices Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Drugs of Abuse Testing Devices Revenue Market Share by Application (2021–2026)
 Table 67. Global Drugs of Abuse Testing Devices Revenue Market Share by Application (2027–2032)
 Table 68. Global Drugs of Abuse Testing Devices Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Drugs of Abuse Testing Devices Price (US$/Unit) by Application (2027–2032)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Abbott Drugs of Abuse Testing Devices Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Thermo Fisher Scientific Drugs of Abuse Testing Devices Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Roche Drugs of Abuse Testing Devices Product
 Table 84. Roche Recent Developments/Updates
 Table 85. Siemens Healthineers Company Information
 Table 86. Siemens Healthineers Description and Business Overview
 Table 87. Siemens Healthineers Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Siemens Healthineers Drugs of Abuse Testing Devices Product
 Table 89. Siemens Healthineers Recent Developments/Updates
 Table 90. Wondfo Biotech Company Information
 Table 91. Wondfo Biotech Description and Business Overview
 Table 92. Wondfo Biotech Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Wondfo Biotech Drugs of Abuse Testing Devices Product
 Table 94. Wondfo Biotech Recent Developments/Updates
 Table 95. Randox Laboratories Company Information
 Table 96. Randox Laboratories Description and Business Overview
 Table 97. Randox Laboratories Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Randox Laboratories Drugs of Abuse Testing Devices Product
 Table 99. Randox Laboratories Recent Developments/Updates
 Table 100. OraSure Company Information
 Table 101. OraSure Description and Business Overview
 Table 102. OraSure Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. OraSure Drugs of Abuse Testing Devices Product
 Table 104. OraSure Recent Developments/Updates
 Table 105. Drager Company Information
 Table 106. Drager Description and Business Overview
 Table 107. Drager Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Drager Drugs of Abuse Testing Devices Product
 Table 109. Drager Recent Developments/Updates
 Table 110. Intec Company Information
 Table 111. Intec Description and Business Overview
 Table 112. Intec Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Intec Drugs of Abuse Testing Devices Product
 Table 114. Intec Recent Developments/Updates
 Table 115. Orient Gene Biotech Company Information
 Table 116. Orient Gene Biotech Description and Business Overview
 Table 117. Orient Gene Biotech Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Orient Gene Biotech Drugs of Abuse Testing Devices Product
 Table 119. Orient Gene Biotech Recent Developments/Updates
 Table 120. Hangzhou Biotest Company Information
 Table 121. Hangzhou Biotest Description and Business Overview
 Table 122. Hangzhou Biotest Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Hangzhou Biotest Drugs of Abuse Testing Devices Product
 Table 124. Hangzhou Biotest Recent Developments/Updates
 Table 125. Assure Tech (Hangzhou) Co Company Information
 Table 126. Assure Tech (Hangzhou) Co Description and Business Overview
 Table 127. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Devices Product
 Table 129. Assure Tech (Hangzhou) Co Recent Developments/Updates
 Table 130. Aotai Bio Company Information
 Table 131. Aotai Bio Description and Business Overview
 Table 132. Aotai Bio Drugs of Abuse Testing Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Aotai Bio Drugs of Abuse Testing Devices Product
 Table 134. Aotai Bio Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Drugs of Abuse Testing Devices Distributors List
 Table 138. Drugs of Abuse Testing Devices Customers List
 Table 139. Drugs of Abuse Testing Devices Market Trends
 Table 140. Drugs of Abuse Testing Devices Market Drivers
 Table 141. Drugs of Abuse Testing Devices Market Challenges
 Table 142. Drugs of Abuse Testing Devices Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drugs of Abuse Testing Devices
 Figure 2. Global Drugs of Abuse Testing Devices Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Drugs of Abuse Testing Devices Market Share by Type: 2025 & 2032
 Figure 4. Urine Testing Product Picture
 Figure 5. Saliva Testing Product Picture
 Figure 6. Blood Testing Product Picture
 Figure 7. Hair and Sweat Testing Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Drugs of Abuse Testing Devices Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Drugs of Abuse Testing Devices Market Share by Application: 2025 & 2032
 Figure 11. Hospital
 Figure 12. Law Enforcement
 Figure 13. Drug Treatment Center
 Figure 14. Laboratory
 Figure 15. Others
 Figure 16. Global Drugs of Abuse Testing Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Drugs of Abuse Testing Devices Market Size (US$ Million), 2021–2032
 Figure 18. Global Drugs of Abuse Testing Devices Sales (K Units), 2021–2032
 Figure 19. Global Drugs of Abuse Testing Devices Average Price (US$/Unit), 2021–2032
 Figure 20. Drugs of Abuse Testing Devices Report Years Considered
 Figure 21. Drugs of Abuse Testing Devices Sales Share by Manufacturers in 2025
 Figure 22. Global Drugs of Abuse Testing Devices Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Drugs of Abuse Testing Devices Players: Market Share by Revenue in Drugs of Abuse Testing Devices in 2025
 Figure 24. Drugs of Abuse Testing Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Drugs of Abuse Testing Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Drugs of Abuse Testing Devices Sales Market Share by Country (2021–2032)
 Figure 27. North America Drugs of Abuse Testing Devices Revenue Market Share by Country (2021–2032)
 Figure 28. United States Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Drugs of Abuse Testing Devices Sales Market Share by Country (2021–2032)
 Figure 31. Europe Drugs of Abuse Testing Devices Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Drugs of Abuse Testing Devices Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Drugs of Abuse Testing Devices Revenue Market Share by Region (2021–2032)
 Figure 39. China Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. China Taiwan Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Indonesia Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Thailand Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Malaysia Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Latin America Drugs of Abuse Testing Devices Sales Market Share by Country (2021–2032)
 Figure 49. Latin America Drugs of Abuse Testing Devices Revenue Market Share by Country (2021–2032)
 Figure 50. Mexico Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Brazil Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Argentina Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Middle East and Africa Drugs of Abuse Testing Devices Sales Market Share by Country (2021–2032)
 Figure 54. Middle East and Africa Drugs of Abuse Testing Devices Revenue Market Share by Country (2021–2032)
 Figure 55. Turkey Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Saudi Arabia Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. UAE Drugs of Abuse Testing Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Global Sales Market Share of Drugs of Abuse Testing Devices by Type (2021–2032)
 Figure 59. Global Revenue Market Share of Drugs of Abuse Testing Devices by Type (2021–2032)
 Figure 60. Global Drugs of Abuse Testing Devices Price (US$/Unit) by Type (2021–2032)
 Figure 61. Global Sales Market Share of Drugs of Abuse Testing Devices by Application (2021–2032)
 Figure 62. Global Revenue Market Share of Drugs of Abuse Testing Devices by Application (2021–2032)
 Figure 63. Global Drugs of Abuse Testing Devices Price (US$/Unit) by Application (2021–2032)
 Figure 64. Drugs of Abuse Testing Devices Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network